Indapamide is not only a diuretic
Authors:
Špinarová L. 1; Špinar J. 2; Vítovec J. 1
Authors‘ workplace:
I. interní kardioangiologická klinika LF MU a FN u sv. Anny v Brně
1; Ústav lékařské fyziologie, LF MU Brno
2
Published in:
Kardiol Rev Int Med 2019, 21(4): 209-212
Overview
Indapamide is not only a simple diuretic, but also a vasodilating substance which acts through the prostaglandines and increases calcium inflow into the myocytes. It is metabolic neutral and does not influence the level of glucose or lipids. It decreases the blood pressure and in combination with perindopril also has mortality evidence from the clinical trials HYVET and ADVANCE. Cerebroprotective data are in the PROGRESS trial. Two recent meta-analyses show data about the effect on regression of left ventricular hypertrophy, which is more pronounced than with hydrochlorothiazide. The decrease of blood pressure is a basic but not the only criterion for the treatment of hypertension. If we decide on the usage of diuretics, indapamide should be preferred.
Keywords:
hypertension – indapamide – left ventricular hypertrophy – patient prognosis
Sources
1. Raggi U, Palumbo P, Moro B et al. Indapamide in the treatment of hypertension in non-insulin-dependent diabetes. Hypertension 1985; 7(6 Pt 2): 157– 160. doi: 10.1161/ 01.hyp.7.6_pt_2.ii157.
2. Madkour H, Gadallah M, Riveline B et al. Indapamide is superior to thiazide in the preservation of renal function in patients with renal insufficiency and systemic hypertension. Am J Cardiol 1996; 77(6): 23B– 25B. doi: 10.1016/ s0002-9149(97)89236-3.
3. Beckett NS, Peters R, Fletcher AE et al. Treatment of hypertension in patients 80 years of age or older. N Engl J Med 2008; 358(18): 1887– 1898. doi: 10.1056/ NEJMoa0801369.
4. Patel A, MacMahon S, Chalmers J et al. ADVANCE Collaborative Group. Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial. Lancet 2007; 370(9590): 829– 840. doi: 10.1016/ S0140-6736(07)61303-8.
5. PROGRESS Collaborative Group. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet 2001; 358(9287): 1033– 1041. doi: 10.1016/ S0140-6736(01)06178-5.
6. Roush GC, Abdelfattah R, Song S et al. Hydrochlorothiazide vs. chlorthalidone, indapamide and potassium-sparing/ hydrochlorothiazide diuretics for reducing left ventricular hypertrophy: A systematic review and metaanalysis. J Clin Hypertens 2018; 20(10): 1507– 1515. doi: 10.1111/ jch.13386.
7. Roush GC, Abdelfattah R, Song S et al. Hydrochlorothiazide and alternative diuretics versus renin – angiotensin system inhibitors for the regression of left ventricular hypertrophy: a head- to- head meta-analysis. J Hypertens 2018; 36(6): 1247– 1255. doi: 10.1097/ HJH.0000000000001691.
Labels
Paediatric cardiology Internal medicine Cardiac surgery CardiologyArticle was published in
Cardiology Review
2019 Issue 4
Most read in this issue
- Indapamide is not only a diuretic
- Propafenone
- News in the treatment of dyslipidaemia
- Management of asymptomatic arrhythmias – a shortened and commented consensus document of the European Heart Rhythm Association (EHRA)